Miller / Evans The Chemist's Companion Guide to Patent Law

1. Auflage 2011
ISBN: 978-1-118-03519-1
Verlag: John Wiley & Sons
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 330 Seiten, E-Book

Written by an individual with experience as both a chemist and a patent attorney, The Chemist's Companion Guide to Patent Law covers everything the student or working chemist needs to know about patentability, explaining important concepts of patent law (such as novelty, non-obviousness, and freedom-to-operate) in easy-to-understand terms. Through abundant examples from case law as well as real-world situations with which a researcher might be faced, this book provides readers with a better understanding of how to put that knowledge into practice.

Autoren/Hrsg.

Miller, Chris P.

Evans, Mark J.

Inhaltsverzeichnis

Disclaimer
Preface.
1 Patent Basics.
1.1 Introduction.
1.2 Patents as Property.
1.3 Patent Rights Are Rights to Exclude.
1.4 Patents Do Not Convey Freedom to Operate the Invention.
1.5 Contrasting Freedom to Operate with Patentability.
1.6 Assignment and Recording of Patents.
1.7 Why Have Patents?
2 The Patent Process.
2.1 An Overview of the Patent Process in the United States.
2.2 Post Grant Procedures at the USPTO.
2.2.a Patent Maintenance Fees.
2.2.b Reissue Applications and Patents.
2.2.c Ex Parte Procedures.
2.2.d Inter Partes Procedures.
2.3 Inequitable Conduct in Patent Prosecution.
3 Prior Art and the Chemical Invention.
3.1 What is Prior Art?
3.2 Prior Art That Can Be Antedated.
3.3 Prior Art That Is an Absolute Bar.
3.4 Section 102 References in Support of ObviousnessRejections.
3.5 Double Patenting.
3.6 Obviousness-Type Double Patenting.
3.7 Prior Art Hypothetical Example 1.
3.8 Hypothetical Example 2.
4 Inventorship.
4.1 Inventorship and Ownership of U.S Patents.
4.2 Patent Validity and Correct Listing of Inventorship.
4.3 Determining Inventorship.
5 Patent Claims.
5.1 Introduction to Claim Language and Structure.
5.2 Independent and Dependent Claim Types.
5.3 Claim Structure.
5.4 Transition Phrases.
5.5 Markush Claiming in Chemical Patents.
5.6 Claim Construction.
6 Basic Requirements of Patentability: Utility.
6.1 The Six Requirements of Patentability.
6.2 Statutory Subject Matter of the Utility Requirement.
6.3 What Makes a Chemical Invention Useful?
7 Basic Requirements of Patentability: Novelty.
7.1 Requirements of the Prior Art to Defeat Novelty.
7.2 Anticipation in Chemical Patents.
7.3 Anticipation of a Claimed Genus by a Species Falling Withinthat Genus.
7.4 Anticipation of a Species Claim by a Prior Art Genus.
7.5 Anticipation of a Range by a Prior Art Species FallingWithin that Range.
7.6 Inherent Anticipation.
8 Basic Requirements of Patentability:Nonobviousness.
8.1 The Basis for the Nonobviousness Requirement.
8.2 Understanding §103(a).
8.3 Graham Factors Analysis of Obviousness.
8.4 Focusing the Obviousness Inquiry: Prima Facie Obviousnessand the Chemical Invention.
8.5 Application of the TSM Test to the Chemical Arts.
8.6 Prior Art as a Whole Must Be Considered for TSM Tests.
8.7 Obviousness and Unpredictability in the Art.
8.8 Unexpected Results as Secondary Indices ofNonobviousness.
8.8.a Unexpected Results Must Be Taught by, or Flow from thePatent Application.
8.8.b Unexpected or Superior Results Can Be Demonstrated Througha Single Property.
8.8.c Unexpected Results: Different in Degree or Different inKind?
8.8.d The Claimed Invention Must Be Tested Against the ClosestPrior Art.
8.9 Prima Facie Obviousness Based Primarily on Similarity ofChemical Structure.
8.9.a Isomers and Homologues.
8.9.b Enantiomers.
8.10 Obviousness of a Species or Genus in Light of a Prior ArtGenus.
8.11 Obviousness of Ranges.
8.12 Changing the Sequence of Ingredient Addition.
8.13 Obviousness of Combining Equivalents Together for SameKnown Purpose.
8.14 Substituting Equivalents Known for the Same Purpose.
8.15 Purified Forms of Compounds or Materials.
9 Basic Requirements of Patentability: Written Description,Enablement, and Best Mode.
9.1 The Written Description Requirement.
9.2 Enablement.
9.3 Best Mode.
Afterword and Sources.
Acknowledgments.
Cases Cited.
Index.

Über Autor(innen)

CHRIS P. MILLER obtained his PhD in organic chemistry fromthe University of Pittsburgh and is a magna cum laude graduate ofthe Temple University Beasley School of Law. Dr. Miller has over adecade of research experience as a medicinal chemist in thepharmaceutical industry and has worked as an associate at a lawfirm as well as served as in-house patent counsel in big pharma andthe biotech industry. Dr. Miller is licensed to practice law beforethe state bar of Pennsylvania and the United States Patent andTrademark Office. He currently is practicing both medicinalchemistry and patent law in the Boston area.
MARK J. EVANS obtained his PhD from NorthwesternUniversity and his MBA from Penn State University; has fifteenyears of pharmaceutical industry experience in the development ofboth small molecule and protein therapeutics at WyethPharmaceuticals and Alexion Pharmaceuticals; and currently works inregulatory affairs in the Philadelphia area.